Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_assertion type Assertion NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_head.
- NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_assertion description "[Furthermore, human AFAR1 catalyses the rate limiting step in the synthesis of the neuromodulator gamma-hydroxybutyrate (GHB) and was found elevated in neurodegenerative diseases such as Alzheimer's and dementia with Lewy bodies (DLB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_provenance.
- NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_assertion evidence source_evidence_literature NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_provenance.
- NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_assertion SIO_000772 18752886 NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_provenance.
- NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_assertion wasDerivedFrom befree-20140225 NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_provenance.
- NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_assertion wasGeneratedBy ECO_0000203 NP939217.RAVWCgf2iwEY3TpTqaiOHAGMmy8n5_VTa0UFC2YAN6oD8130_provenance.